Healthcare data has proven to be of little value to both policy makers and to the public. Instead of data,...
Read moreHealthcare is irrational and patients behave irrationally. Yet we continue to develop healthcare models assuming that patients are rational. Behavioral...
Read moreThe fault is not in our stars, but in ourselves. In the subtle, implicit biases we continue to carry across...
Read moreLiberty is the foundation of American culture. But liberty in healthcare often handicaps patients who are less educated about their...
Read moreThe vaccine has arrived and the roll-out has begun, with many of the high-risk already vaccinated. But we should remain...
Read moreWhile most of the world was relaxing over the holidays, we at Daily Remedy were struggling with COVID-19. And we...
Read moreThe pandemic has proven how complex the relationship between healthcare policy and economics can be. However, the mental constraints may...
Read moreThe vaccine roll-out is well on its way, and already the early rifts are starting to form. But the ensuing...
Read moreThe year 2020 is finally coming to an end, but the end of the pandemic seems nowhere in sight. While...
Read moreThe pandemic has accelerated the adoption of consumerism principles throughout healthcare. But not everybody is adopting these principles uniformly. And...
Read moreNudges have recently grown in popularity within healthcare as the field continues to integrate principles of behavioral economics. But nudges...
Read moreHope springs eternal as we transition into a new administration with a new, and hopefully more scientific approach to the...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy